Mats Lindskog

Mats Lindskog joins Oblique Therapeutics as CBO- Chief Business Officer in Stockholm Office. In his role, Mats will be responsible for business development initiatives to secure overall company growth and to build and strengthen business relations with current and new partners.

Mats has extensive knowledge and experience in areas that will be pivotal in his role at Oblique: Business development, pharmaceutical sales, and antibody technology.

He holds a Master of Science in biotechnology and a PhD within Antibody-based proteomics, both from the Royal Institute of Technology (KTH) in Stockholm. Following his studies Mats worked at start-up biotech companies within antibody production and protein-protein interaction studies and within pharmaceutical Sales and Marketing, specifically within Oncology.

Mats has since then held various executive positions at pharma companies within Business Unit Leadership, Strategy & Operations, Business Excellence and Commercial Operations.